Robert W. Duggan - 30 Nov 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
30 Nov 2023
Net transactions value
+$1,385,673
Form type
4
Filing time
04 Dec 2023, 19:37:05 UTC
Previous filing
01 Dec 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $1,385,673 +152,944 +255% $9.06 212,944 30 Nov 2023 See footnote F1, F2
holding PLSE Common Stock 36,551,461 30 Nov 2023 Direct
holding PLSE Common Stock 492,069 30 Nov 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Volume-weighted average price.
F2 Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
F3 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.